Altamira Therapeutics .(CYTO) - 2018 Q4 - Earnings Call Presentation

Innovative Treatments for Inner Ear Disorders 4th Quarter 2018 Financial Results & Business Update March 14, 2019 NASDAQ: EARS Forward-looking Statements This presentation and the accompanying oral commentary may contain statements may contain statements that constitute "forwardlooking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are statements other than historical facts and may include stateme ...